C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brynjulf Mortensen, pHD
Bactolife A/S
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University Hospital
Atlanta, Georgia, United States
Colleen S Kraft, MD, MScNirja Mehta, MDRecruiting - Corewell Health William Beaumont University Hospital
Royal Oak, Michigan, United States
Matthew Sims, Dr.Recruiting - Mayo Clinic, Minnesota
Rochester, Minnesota, United States
Darrell s Pardi, Dr.Sahil Khanna, Dr.Recruiting - University of Wisconsin-Madison
Madison, Wisconsin, United States
Nasia Safdar, MD, PhD, Prof.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2026
- Primary completion
- 15 Oct 2026
- Completion
- 15 Oct 2026
- Last update posted
- 15 Jun 2026
- Registered enrollment
- 60
- Registry id
- NCT07250724
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.